Litigation
The Department of Health and Human Services’ Office for Civil Rights March 18 released updated guidance for HIPAA-covered entities and business associates on using online tracking technologies.
A federal court March 8 vacated the National Labor Relations Board’s 2023 rule for determining joint-employer status under the National Labor Relations Act and reinstated the 2020 rule, agreeing with the U.S. Chamber of Commerce and other plaintiffs that the new rule violates the Administrative…
A friend-of-the-court brief in support of a Louisiana law that prohibits drug companies from denying Louisiana hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies.
The AHA, joined by five other national associations representing hospitals, today urged the U.S. Supreme Court to review a case challenging how the Department of Health and Human Services applies Congress’ formula for calculating Disproportionate Share Hospital payments.
Thirty hospitals and health systems friend-of-the-court briefs supporting the AHA in its lawsuit challenging a Department of Health and Human Services’ Office for Civil Rights rule that restricts the use of standard third-party web technologies that capture IP addresses on portions of hospitals’…
Seventeen state hospital associations friend-of-the-court brief supporting the AHA in its lawsuit challenging a Department of Health and Human Services’ Office for Civil Rights rule that restricts the use of standard third-party web technologies that capture IP addresses on portions of hospitals’…
AHA Amicus Brief in Adventist Health System Sunbelt Healthcare Corp., Vs. Multiplan, Inc., litigation.
The U.S. District Court for the Eastern District of Texas for a third time ruled to set aside certain regulations implementing the No Surprises Act.
The Department of Justice in February abruptly withdrew three policy statements on health care antitrust enforcement.
In early February 2023, a senior U.S. Department of Justice Antitrust Division (DOJ) official
abruptly announced that DOJ had withdrawn three longstanding statements of antitrust
enforcement policy in health care (Policy Statements).